25-Hydroxyvitamin D levels are related to hyperinsulinemia in polycystic ovary syndrome

Gynecological Endocrinology

Volumn 30, Issue 8, 2014, Pages 557-560

  Güdücü, Nilgün ^a   Görmüş, Uzay ^a   Kutay, Salih Serdar ^b   Kavak, Zehra Neşe ^c   Dünder, Ilkkan ^a  

^a ISTANBUL BILIM UNIVERSITY   (Turkey)

^b Department of Biochemistry Istanbul Bilim University ^*  (Turkey)

^c MARMARA UNIVERSITY   (Turkey)

Author keywords

Insulin resistance; Obesity; Polycystic ovary syndrome; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; INSULIN; 25-HYDROXYVITAMIN D; VITAMIN D;

ADULT; ARTICLE; BODY MASS; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; METABOLIC DISORDER; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; TURK (PEOPLE); VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; ANALOGS AND DERIVATIVES; BLOOD; COMPLICATION; HYPERINSULINISM; OBESITY; POLYCYSTIC OVARY SYNDROME; YOUNG ADULT;

ADULT; BODY MASS INDEX; CASE-CONTROL STUDIES; FEMALE; HUMANS; HYPERINSULINISM; INSULIN; INSULIN RESISTANCE; OBESITY; POLYCYSTIC OVARY SYNDROME; VITAMIN D; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 84904420662     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2014.910189     Document Type: Article

References (32)

1. Aprinodze T, Essah PA, Iuorno MJ, Nestler JE. Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2004;90:1929-35.
2. Ehrmann DA. Insulin resistance and polycystic ovary syndrome. Curr Diab Rep 2002;2:71-6.
3. Kandarakis ED, Papavassilou AG. Molecular mechanisms of insulin resistance in polycystic ovary syndrome Trends Mol Med 2006;12: 352-62.
4. Scragg R, Jackson R, Holdaway IM, et al. Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: a community-based study. Int J Epidemiol 1990;19:559-63. (Pubitemid 20331800)
5. Chiu KC, Chu A, Go VL, Saad MF. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 2004;79:820-5. (Pubitemid 41103882)
6. Homburg R, Amsterdam A. Polycystic ovary syndrome - loss of the apoptotic mechanism in the ovarian follicles? J Endocrinol Invest 1998;21:552-7. (Pubitemid 28532462)
7. Tilly JL. Apoptosis and ovarian function. Rev Reprod 1996;1: 162-72. (Pubitemid 27099362)
8. Holick MF. Vitamin D deficiency. N Engl J Med 2007;357:266-81.
9. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and longterm health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19-25.
10. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Metab Endocrinol 1999;84:3666-72. (Pubitemid 30645223)
11. Nestler JE, Reilly ER, Cheang KI, et al. A pilot study: effects of decreasing serum insulin with diazoxide on vitamin D levels in obese women with polycystic ovary syndrome. Trans Am Clin Climatol Assoc. 2012;123:209-19.
12. Wehr E, Trummer O, Giuliani A, et al.Vitamin D associated polymorphisms are related to insulin resistance and vitamin D deficiency in PCOS. Eur J Endocrinol 2011;164:741-9.
13. Mahmoudi T, Gourabi H, Ashrafi M, et al. Calciotropic hormones, insulin resistance, and the polycystic ovary syndrome. Fertil Steril 2010;93:1208-14.
14. Li HW, Brereton RE, Anderson RA, et al. Vitamin D deficiency is common and associated with metabolic risk factors in patients with polycystic ovary syndrome. Metab Clin Exp 2011;60:1475-81.
15. Wehr E, Pilz S, Schweighofer N, et al. Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome. Eur J Endocrinol 2009;161:575-82.
16. Maestro B, Molero S, Bajo S, et al. Transcriptional activation of the human insulin receptor gene by 1,25-dihydroxyvitamin D[3]. Cell Biochem Funct 2002;20:227-32.
17. Maestro B, Davila N, Carranza MC, Calle C. Identification of a vitamin D response element in the human insulin receptor gene promoter. J Steroid Biochem Mol Biol 2003;84:223-30. (Pubitemid 36514839)
18. Milner RD, Hales CN. The role of calcium and magnesium in insulin secretion from rabbit pancreas studied in vitro. Diabetologia 1967;3:47-9.
19. Shoelson SE, Herrero L, Naaz A. Obesity, inflammation, and insulin resistance. Gastroenterology 2007;132:2169-80. (Pubitemid 46693756)
20. Hahn S, Haselhorst U, Tan S, et al. Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes 2006;114:577-83. (Pubitemid 46087264)
21. Patra SK, Nasrat H, Goswami B, et al. Vitamin D as a predictor of insulin resistance in polycystic ovarian syndrome. Diabetes Metab Syndr 2012;6:146-9.
22. Selimoglu H, Duran C, Kiyici S, et al. The effect of vitamin D replacement therapy on insulin resistance and androgen levels in women with polycystic ovary syndrome. J Endocrinol Invest 2010; 33:234-8.
23. Kotsa K, Yavropoulou MP, Anastasiou O, Yovos JG. Role of vitamin D treatment in glucose metabolism in polycystic ovary syndrome. Fertil Steril 2009;92:1053-8.
24. Ardabili HR, Gargari BP, Farzadi L, et al. Vitamin D supplementation has no effect on insulin resistance assessment in women with polycystic ovary syndrome and vitamin D deficiency. Nutr Res 2012;32:195-201.
25. Pal L, Berry A, Coraluzzi L, et al. Therapeutic implications of vitamin D and calcium in overweight women with polycystic ovary syndrome. Gynecol Endocrinol 2012;28:965-8.
26. Stepto NK, Cassar S, Joham AE, et al. Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp. Hum Reprod 2013;28: 777-84.
27. Panidis D, Balaris C, Farmakiotis D, et al. Serum parathyroid hormone concentrations are increased in women with polycystic ovary syndrome. Clin Chem 2005;51:1691-7. (Pubitemid 41233105)
28. Yildizhan R, Kurdoglu M, Adali E, et al. Serum 25-hydroxyvitamin D concentrations in obese and non-obese women with polycystic ovary syndrome. Arch Gynecol Obstet 2008;280:559-63.
29. Muscogiuri G, Policola C, Prioletta A, et al. Low levels of 25(OH)D and insulin-resistance: 2 unrelated features or a cause-effect in PCOS? Clin Nutr. 2012;31:476-80.
30. Lagunova Z, Porojnicu AC, Lindberg F, et al. The dependency of vitamin D status on body mass index, gender, age and season. Anticancer Res 2009;29:3713-20.
31. Parikh G, Varadinova M, Suwandhi P, et al. Vitamin D regulates steroidogenesis and insulin-like growth factor binding protein-1 (IGFBP-1) production in human ovarian cells. Horm Metab Res 2010;42:754-7.
32. Arunabh S, Pollack S, Yeh J, Aloia JF. Body fat content and 25- hydroxyvitamin D levels in healthy women. J Clin Endocrinol Metab 2003;88:157-61. (Pubitemid 36115158)